Kazuya Yamagata

Prof. Dr. Kazuya Yamagata

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2014 in Cell Metabolism
Verified
Journal Article
Closed access
TYTatsuya Yoshizawa
Tatsuya Yoshizawa
FKFazlul Karim
Fazlul Karim
YSYoshifumi Sato
Yoshifumi Sato
TSTakafumi Senokuchi
Takafumi Senokuchi
KMKeishi Miyata
Keishi Miyata
KYKazuya Yamagata
Kazuya Yamagata

1 April 2011 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
KYKazuya Yamagata
Kazuya Yamagata
TSTakafumi Senokuchi
Takafumi Senokuchi
MLMeihong Lu
Meihong Lu
MTMakoto Takemoto
Makoto Takemoto
FKFazlul Karim
Fazlul Karim
WSWen-Jie Song
Wen-Jie Song

12 April 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
YMYoshikazu Miyasato
Yoshikazu Miyasato
TYTatsuya Yoshizawa
Tatsuya Yoshizawa
YSYoshifumi Sato
Yoshifumi Sato
TNTerumasa Nakagawa
Terumasa Nakagawa
YMYuko Miyasato
Yuko Miyasato
KYKazuya Yamagata
Kazuya Yamagata
Cisplatin-induced acute kidney injury (AKI) has been recognized as one of cisplatin’s serious side effects, limiting its use in cancer therapy. Sirtuin 1 (SIRT1) and SIRT3 play protective roles against cisplatin-induced kidney injury. However, the role of SIRT7 in cisplatin-induced kidney injury is not yet known. In this study, we found that Sirt7 knockout (KO) mice were resistant to cisplatin-induced AKI. Furthermore, our studies identified that loss of SIRT7 decreases the expression of tumor necrosis factor-α (TNF-α) by regulating the nuclear expression of the transcription factor nuclear factor kappa B. It has been reported that cisplatin-induced nephrotoxicity is mediated by TNF-α. Our results indicate that SIRT7 plays an important role in cisplatin-induced AKI and suggest the possibility of SIRT7 as a novel therapeutic target for cisplatin-induced nephrotoxicity.

12 December 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
YSYoshifumi Sato
Yoshifumi Sato
MIMasahiro Inoue
Masahiro Inoue
TYTatsuya Yoshizawa
Tatsuya Yoshizawa
KYKazuya Yamagata
Kazuya Yamagata
Pancreatic β-cell failure is central to the development and progression of type 2 diabetes. We recently demonstrated that β-cells become hypoxic under high glucose conditions due to increased oxygen consumption and that the pancreatic islets of diabetic mice but not those of control mice are moderately hypoxic. However, the impact of moderate hypoxia on β-cell number and function is unknown. In the present study, moderate hypoxia induced a hypoxic response in MIN6 cells, as evidenced by increased levels of HIF-1α protein and target genes. Under these conditions, a selective downregulation of Mafa, Pdx1, Slc2a2, Ndufa5, Kcnj11, Ins1, Wfs1, Foxa2, and Neurod1, which play important roles in β-cells, was also observed in both MIN6 cells and isolated pancreatic islets. Consistent with the altered expression of these genes, abnormal insulin secretion was detected in hypoxic MIN6 cells. Most of the hypoxia-induced gene downregulation in MIN6 cells was not affected by the suppression of HIF-1α, suggesting a HIF-1–independent mechanism. Moderate hypoxia also induced apoptosis in MIN6 cells. These results suggest that hypoxia is a novel stressor of β-cells and that hypoxic stress may play a role in the deterioration of β-cell function.

1 January 2014
Verified
Book Chapter
Closed access
KYKazuya Yamagata
Kazuya Yamagata

1 September 2020 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
YKYuichi Kariba
Yuichi Kariba
TYTatsuya Yoshizawa
Tatsuya Yoshizawa
YSYoshifumi Sato
Yoshifumi Sato
TTTomonori Tsuyama
Tomonori Tsuyama
EAEiichi Araki
Eiichi Araki
KYKazuya Yamagata
Kazuya Yamagata